MOLECULAR GENETIC MARKERS AS PREDICTORS OF TUMOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR RECTAL CANCER

MOLECULAR GENETIC MARKERS AS PREDICTORS OF TUMOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR RECTAL CANCER

The review presents the mechanisms involved in the biological behavior of rectal cancer cells. The tumor response to neoadjuvant chemoradiotherapy was evaluated. The characteristics of proliferative activity, apoptosis, cell adhesion, and migration of rectal cancer cells influenced by chemotherapy w...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. R. Altybaev, S. G. Afanasyev, M. V. Zavyalova, I. V. Stepanov, D. A. Sorokin
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2016-11-01
Series:	Сибирский онкологический журнал
Subjects:	rectal cancer neoadjuvant chemoradiation tumor response immunohistochemistry genetic markers
Online Access:	https://www.siboncoj.ru/jour/article/view/408
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MRI-PATHOLOGICAL PARALLELS WITH THE COMPLETE TUMOR RESPONSE TO NEOADJUVANT CHEMORADIATION TREATMENT OF RECTAL CANCER
by: T. P. Berezoskaya, et al.
Published: (2019-06-01)

A randomized phase II/III trial of rosuvastatin with neoadjuvant chemo-radiation in patients with locally advanced rectal cancer
by: Prachi S. Patil, et al.
Published: (2025-03-01)

To compare and determine the diagnostic accuracy of [18F]-fluorodeoxyglucose positron emission tomography scan in predicting pathological response in operated carcinoma esophagus patients after initial neoadjuvant chemoradiation and neoadjuvant chemotherapy
by: Neelam Sharma, et al.
Published: (2018-04-01)

Fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy
by: Daigo Kobayashi, et al.
Published: (2018-09-01)

Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01)

Modern principles of neoadjuvant therapy for rectal cancer
by: A. M. Karachun, et al.
Published: (2025-05-01)

Sequencing of chemotherapy in total neoadjuvant treatment for rectal cancer does not predict radiation-induced lymphopenia
by: Orazem Miha, et al.
Published: (2025-06-01)

COMBINED TREATMENT OF OPERABLE RECTAL CANCER WITH NEGATIVE PROGNOSIS FACTORS: A PROSPECTIVE STUDY
by: S. O. Kochkina, et al.
Published: (2021-08-01)

Understanding and considerations of radiation-induced rectal and anal injury after neoadjuvant chemoradiotherapy for rectal cancer
by: Zhu Xiaoming, et al.
Published: (2023-10-01)

Response Assessment after Neoadjuvant Chemoradiotherapy in Rectal Cancer
by: Anuradha Chandramohan, et al.
Published: (2025-05-01)

The Influence of Neoadjuvant Chemoradiotherapy on Muscle Mass in Patients with Rectal Cancer
by: Gregory Simpson, et al.
Published: (2019-07-01)

The effect of neoadjuvant chemoradiation therapy in resectable pancreatic cancer was independent of intratumoral vascularization
by: Tomomi Yasue, et al.
Published: (2025-07-01)

Upfront surgery, neoadjuvant chemoradiotherapy, or neoadjuvant chemotherapy for rectal cancer with lateral lymph node metastasis: A multicenter MRI and lateral lymph node dissection study
by: Takuya Miura, et al.
Published: (2025-03-01)

Neoadjuvant chemoradiation and surgical excision versus definitive radiotherapy for locally advanced cervix uteri carcinoma: in terms of early and late complications and locoregional recurrence
by: Hisham Khalifa, et al.
Published: (2025-06-01)

Impact of pathological complete response following neoadjuvant chemotherapy (gemcitabine, nab-paclitaxel, S-1) and radiation for borderline resectable pancreatic cancer: a case report and review of literature
by: Mitsuru Kinoshita, et al.
Published: (2022-09-01)

Neoadjuvant chemotherapy versus long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis of 5,168 cases
by: Wenjie Zhou, et al.
Published: (2025-06-01)

Transanal endoscopic microsurgery in the treatment of patients with benign neoplasms and early rectal cancer
by: V. A. Avdeenko, et al.
Published: (2022-01-01)

Daxx Variation as a Potential Predictive Marker of the Therapeutic Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
by: Xi Zhu, et al.
Published: (2025-03-01)

Metformin’s impact on tumor regression grade in diabetic patients with rectal cancer undergoing neoadjuvant chemoradiotherapy
by: Nai-Yu Lin, et al.
Published: (2025-07-01)

MOLECULAR-GENETIC MARKERS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY WITH ANTHRACYCLINES IN BREAST CANCER PATIENTS
by: P. V. Kazantseva, et al.
Published: (2016-07-01)

EGFR EXPRESSION IN RECTAL CANCER, RELATION TO THE FREAQUENCY OF LYMPH NODE METASTASIS
by: I. V. Stepanov, et al.
Published: (2017-06-01)

Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
by: V. A. Grigorenko, et al.
Published: (2021-07-01)

Short‐Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients
by: Rongxin Zhang, et al.
Published: (2025-08-01)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy for locally advanced rectal cancer: 3-year survival from a phase 2 study
by: Zhenyu Lin, et al.
Published: (2025-05-01)

RELATIONSHIP BETWEEN PARAMETERS OF TUMOR NEOANGIOGENESIS AND LYMPHOGENOUS METASTASIS IN PATIENTS WITH RECTAL CANCER
by: I. V. Stepanov, et al.
Published: (2017-07-01)

Down-staging following neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: Does timing of surgery really matter?
by: Bhawna Sirohi, et al.
Published: (2014-01-01)

CD8-positive lymphocyte infiltration as a marker of anti-tumor immune response in rectal cancer: pre- and post-neoadjuvant radiotherapy comparison
by: Samaneh Salarvand, et al.
Published: (2025-09-01)

SURGICAL TREATMENT OF REGIONAL RECURRENCE FROM GASTRIC CANCER AFTER MULTIMODAL TREATMENT WITH NEOADJUVANT CHEMORADIOTHERAPY (A CASE REPORT)
by: V. Yu. Skoropad, et al.
Published: (2018-05-01)

Combined application of spiral computed tomography and transrectal ultrasound in the evaluation of neoadjuvant chemoradiotherapy in rectal cancer
by: L. M. Vasko, et al.
Published: (2019-02-01)

Intra-arterial chemoembolization as a component of neoadjuvant treatment of rectal cancer. Literature review
by: R. E. Kalinin, et al.
Published: (2024-11-01)

Predictors of pathological complete response after total neoadjuvant treatment using short course radiotherapy for locally advanced rectal cancer
by: Haythem Yacoub, et al.
Published: (2025-03-01)

Diagnostic Accuracy of Post-Neoadjuvant Treatment Restaging Magnetic Resonance Imaging in Rectal Cancer in the Era of Total Neoadjuvant Treatment
by: Gaurav Ravi Kumar, et al.
Published: (2025-05-01)

Correlation analysis of tertiary lymphoid structure parameters with the prognosis of patients with locally advanced rectal cancer after neoadjuvant chemotherapy: a retrospective study
by: Yingjian Jiang, et al.
Published: (2025-04-01)

Effect of neoadjuvant therapy on textbook outcomes in minimally invasive rectal cancer surgery
by: Guiqi Zhang, et al.
Published: (2025-04-01)

Prediction of response to neoadjuvant chemotherapy in patients with muscle-invasive urothelial bladder cancer: role of immune-related gene expression
by: Hadeer Mahmoud, et al.
Published: (2025-07-01)

Safety and efficacy of individualized modified total neoadjuvant therapy for low locally advanced rectal cancer
by: Qing Ye, et al.
Published: (2025-07-01)

Tumor Response to Neoadjuvant Long-Course Chemoradiotherapy Depends on the Rectal Cancer Patient Gender
by: Velda Smajlbegović, et al.
Published: (2024-01-01)

PATHOLOGICAL RESPONSE OF GASTRIC CANCER TO NEOADJUVANT PROLONGED CHEMORADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY
by: Е. F. Lushnikov, et al.
Published: (2016-02-01)

Value of synthetic MRI in predicting treatment response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
by: WANG Kangning, ZHU Lan, FENG Weiming, XIA Yihan, SHI Bowen, ZHANG Huan
Published: (2025-04-01)

[Comment] Brazil-TNT : a randomized phase 2 trial of neoadjuvant chemoradiation followed by FOLFIRINOX versus chemoradiation for stage Ⅱ/Ⅲ rectal cancer
by: Li Laiyuan, et al.
Published: (2024-08-01)